The JAK2 V617F mutational status and allele burden may be related with the risk of venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms

2014/11/17 by Martyna Borowczyk, Marzena Wojtaszewska, Krzysztof Lewandowski +10 · 1 citation
Medicine · #Coagulation, Bradykinin, Polyphosphates, and Angioedema #Eosinophilic Disorders and Syndromes #Myeloproliferative Neoplasms: Diagnosis and Treatment

paper · doi:10.1016/j.thromres.2014.11.006

openalex publication_date 2014/11/17 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30

Citations

• Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia
• Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)

Cited by

• JAK2 allele burden is correlated with a risk of venous but not arterial thrombosis